Search Results - "Pan, Samuel M"

Chemo4MetPanc: A phase II study with combination chemotherapy (gemcitabine and nab-paclitaxel), chemokine (C-X-C) motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) in metastatic treatment naïve pancreas adenocarcinoma (PDAC) by Pellicciotta, Ilenia, Alouani, Emily Linda, Raufi, Alexander, Pan, Samuel M, Hu, Jianhua, Manji, Gulam Abbas

“…Abstract only TPS454 Background: Pancreas adenocarcinoma (PDAC) is an aggressive cancer projected to be the second leading cause of cancer-related death in the…”
Get full text

Updated OS of patients with AL amyloidosis after CAEL-101 by Hughes, Michael Sang, Pan, Samuel M, Chakraborty, Rajshekhar, Raikhelkar, Jayant, Maurer, Mathew, Mapara, Markus Y., Eisenberger, Andrew, Lentzsch, Suzanne, Bhutani, Divaya

“…8026 Background: Morbidity and mortality remain high in immunoglobulin light chain (AL) amyloidosis due to organ involvement despite hematologic remission. Few…”
Get full text

Survival outcomes associated with liver-directed therapies in patients with metastatic uveal melanoma by Caplan, Michael M, Chen, Lanyi Nora, Krishnasamy, Venkatesh, Sperling, David, Weintraub, Joshua, DeStephano, David, Pan, Samuel M, McDonnell, Diana, Marr, Brian P, Carvajal, Richard D., Khan, Shaheer

“…9590 Background: Metastatic uveal melanoma (mUM) is characterized by a hepatotropic pattern of spread and poor outcomes. Tebentafusp, the only FDA approved…”
Get full text

CheMo4METPANC: A phase 2 study with combination chemotherapy (gemcitabine and nab-paclitaxel), chemokine (C-X-C) Motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) in metastatic treatment-naïve pancreas adenocarcinoma by Manji, Gulam Abbas, May, Michael S., Pellicciotta, Ilenia, Sta Ana, Sarah, Sender, Naomi, Pan, Samuel M, Ross, Isabelle, Hu, Jianhua, Shi, Qian, Raufi, Alexander G

“…TPS4200 Background: Metastatic pancreatic ductal adenocarcinoma (mPDAC) is a uniformly fatal disease for which treatments result in limited benefit. Failure of…”
Get full text

CheMo4METPANC: A randomized phase 2 study with combination chemotherapy (gemcitabine and nab-paclitaxel), chemokine (C-X-C) motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) compared to chemotherapy alone in metastatic treatment-naïve pancreatic adenocarcinoma by Manji, Gulam Abbas, May, Michael S., Chalabi, Morteza, Pellicciotta, Ilenia, Sta Ana, Sarah, Sender, Naomi, Pan, Samuel M, Ross, Isabelle, Wang, Shikun, Izar, Benjamin, Wu, Linda, Labadie, Brian William, Bates, Susan Elaine, Shi, Qian, Raufi, Alexander G

“…TPS4208 Background: Metastatic pancreatic ductal adenocarcinoma (mPDAC) carries a 5-year relative survival of 3%. Immune checkpoint inhibitors have thus far…”
Get full text

Contribution of neoadjuvant chemotherapy and radiation therapy (intensity-modulated radiation therapy with concurrent chemotherapy versus stereotactic body radiation therapy alone) on tumor volume regression in patients with borderline resectable or locally advanced pancreatic ductal adenocarcinoma: A single institution experience by Jamison, Jacob K., Cho, Hope, May, Michael S., Luk, Lyndon, Flusberg, Milana, Kobi, Mariya, Beylergil, Volkan, Skorohodova, Ksenia, Raufi, Alexander G, Horowitz, David Paul, Kluger, Michael D., Pan, Samuel M, Kachnic, Lisa A., Schrope, Beth, Bates, Susan Elaine, White, Ruth Aroon, Moy, Ryan H., Wu, Linda, Chabot, John A., Manji, Gulam Abbas

“…707 Background: Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a minority of patients (pts) eligible for curative resection. Pts with…”
Get full text

Improved survival in patients with lung only recurrence after surgical resection of pancreatic ductal adenocarcinoma by May, Michael S., Michel, Alissa, Lee, Tristan, Wong, Winston, Jamison, Jacob K.R., Manrique, David, Pan, Samuel M, Hu, Jianhua, Safyan, Rachael A, Raufi, Alexander, Kluger, Michael, Bates, Susan Elaine, Chabot, John A., Manji, Gulam Abbas

“…Abstract only 608 Background: Recurrence rates after resection of pancreatic ductal adenocarcinoma (PDA) can be up to 80%. Prior data suggests that initial…”
Get full text

Effect of mammography screening frequency on false-positive biopsy rates and detection of local recurrence among breast cancer survivors by McGuinness, Julia E, Manley, Haley, Yuan, Sarah, Pan, Samuel M, Zhao, Ziyi, Ha, Richard D., Genkinger, Jeanine M, Crew, Katherine D.

“…Abstract only 7016 Background: Current guidelines recommend that women with a history of early-stage breast cancer treated with breast-conserving therapy (BCT)…”
Get full text

A randomized phase Ib/II study of intermittent androgen deprivation therapy plus nivolumab with or without interleukin-8 blockade in men with hormone-sensitive prostate cancer (MAGIC-8) by Dallos, Matthew, Pan, Samuel M, Chaimowitz, Matthew, Stein, Mark N., Lim, Emerson A., Hawley, Jessica, Sender, Naomi, Sta Ana, Sarah, Runcie, Karie, Sternberg, Cora N., Bilen, Mehmet Asim, Mille, Patrick Johnston, Kelly, William Kevin, Tagawa, Scott T., Nanus, David M., Drake, Charles G.

“…5082 Background: Immunotherapy has limited efficacy in castration-resistant prostate cancer. Androgen deprivation therapy (ADT) has significant…”
Get full text

Neoadjuvant gemcitabine, docetaxel, and capecitabine results in comparable surgical outcomes to modified FOLFIRINOX in patients with pancreatic ductal adenocarcinoma who also receive radiation: A single institution experience by Wong, Winston, Jamison, Jacob K.R., May, Michael S., Michel, Alissa, Lee, Tristan, Manrique, David, Raufi, Alexander, Pan, Samuel M, Safyan, Rachael A, Horowitz, David Paul, Schrope, Beth, Kluger, Michael, Kachnic, Lisa A., Hu, Jianhua, Bates, Susan Elaine, Chabot, John A., Manji, Gulam Abbas

“…Abstract only 565 Background: Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis with a minority of patients (pts) eligible for curative resection…”
Get full text

The Relationship Between Reticular Pseudodrusen and Severity of AMD by Kovach, Jaclyn L., MD, Schwartz, Stephen G., MD, MBA, Agarwal, Anita, MD, Brantley, Milam A., MD, PhD, Pan, Samuel S., MS, Haines, Jonathan L., PhD, Scott, William K., PhD, Pericak-Vance, Margaret A., PhD

Get full text